Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Hoffmann

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|June 21, 2021
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse ModelMatthias Scheiner, Matthias Hoffmann, Feng He, et al.
IEEE Transactions on Medical Imaging|October 7, 2015
Electrophysiology Catheter Detection and Reconstruction From Two Views in Fluoroscopic ImagesMatthias Hoffmann, Alexander Brost, Martin Koch, et al.
Acta Dermato-Venereologica|May 16, 2002
High-resolution laser Doppler perfusion imaging aids in differentiating between benign and malignant melanocytic skin tumoursMarkus Stücker, Martina Esser, Matthias Hoffmann, et al.
The Journal of Allergy and Clinical Immunology|September 6, 2012
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitisNatalija Novak, Thomas Bieber, Matthias Hoffmann, et al.
Clinical Oral Investigations|May 11, 2012
Wear behavior of different double-crown systemsJörg Engels, Oliver Schubert, Jan-Frederik Güth, et al.
CNS Neuroscience & Therapeutics|June 18, 2024
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's diseaseAllison Carles, Matthias Hoffmann, Matthias Scheiner, et al.
Optics Express|June 6, 2009
Terahertz time-domain spectroscopy and imaging of artificial RNABernd Fischer, Matthias Hoffmann, Hanspeter Helm, et al.
Redox Biology|January 14, 2020
7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivoSandra Gunesch, Matthias Hoffmann, Carolina Kiermeier, et al.
Journal of the American Chemical Society|February 9, 2022
Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition <i>in Vitro</i> and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon IrradiationMatthias Scheiner, Alexandra Sink, Matthias Hoffmann, et al.
Swiss Medical Weekly|September 21, 2021
Vaccination willingness for COVID-19 among healthcare workers: a cross-sectional survey in a Swiss cantonKathrin Zürcher, Catrina Mugglin, Matthias Egger, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|June 21, 2021
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse ModelMatthias Scheiner, Matthias Hoffmann, Feng He, et al.
IEEE Transactions on Medical Imaging|October 7, 2015
Electrophysiology Catheter Detection and Reconstruction From Two Views in Fluoroscopic ImagesMatthias Hoffmann, Alexander Brost, Martin Koch, et al.
Acta Dermato-Venereologica|May 16, 2002
High-resolution laser Doppler perfusion imaging aids in differentiating between benign and malignant melanocytic skin tumoursMarkus Stücker, Martina Esser, Matthias Hoffmann, et al.
The Journal of Allergy and Clinical Immunology|September 6, 2012
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitisNatalija Novak, Thomas Bieber, Matthias Hoffmann, et al.
Clinical Oral Investigations|May 11, 2012
Wear behavior of different double-crown systemsJörg Engels, Oliver Schubert, Jan-Frederik Güth, et al.
CNS Neuroscience & Therapeutics|June 18, 2024
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's diseaseAllison Carles, Matthias Hoffmann, Matthias Scheiner, et al.
Optics Express|June 6, 2009
Terahertz time-domain spectroscopy and imaging of artificial RNABernd Fischer, Matthias Hoffmann, Hanspeter Helm, et al.
Redox Biology|January 14, 2020
7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivoSandra Gunesch, Matthias Hoffmann, Carolina Kiermeier, et al.
Journal of the American Chemical Society|February 9, 2022
Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition <i>in Vitro</i> and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon IrradiationMatthias Scheiner, Alexandra Sink, Matthias Hoffmann, et al.
Swiss Medical Weekly|September 21, 2021
Vaccination willingness for COVID-19 among healthcare workers: a cross-sectional survey in a Swiss cantonKathrin Zürcher, Catrina Mugglin, Matthias Egger, et al.
Pageof 15